Fidelity Disruptive Medicine ETF (FMED)
NASDAQ: FMED · Real-Time Price · USD
32.66
+0.40 (1.25%)
Aug 25, 2026, 4:00 PM EDT - Market closed
FMED Holdings Information
FMED is an equity ETF with a total of 79 individual holdings. The top holdings are Fidelity Securities Lending Cash Central Fund stock at 5.94%, 10x Genomics at 5.26%, Thermo Fisher Scientific at 3.90%, Danaher at 3.83%, and LifeStance Health Group at 3.14%.
Total Holdings
79
Top 10 Percentage
35.81%
Asset Class
Equity
ETF Category
Health
Assets
52.93M
PE Ratio
39.71
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | Fidelity Securities Lending Cash Central Fund | 5.94% |
| 2 | TXG | 10x Genomics, Inc. | 5.26% |
| 3 | TMO | Thermo Fisher Scientific Inc. | 3.90% |
| 4 | DHR | Danaher Corporation | 3.83% |
| 5 | LFST | LifeStance Health Group, Inc. | 3.14% |
| 6 | RVMD | Revolution Medicines, Inc. | 3.03% |
| 7 | COGT | Cogent Biosciences, Inc. | 2.87% |
| 8 | ARGX | argenx SE | 2.81% |
| 9 | ILMN | Illumina, Inc. | 2.65% |
| 10 | NTRA | Natera, Inc. | 2.39% |
| 11 | EPA: DIM | Sartorius Stedim Biotech S.A. | 2.25% |
| 12 | ISRG | Intuitive Surgical, Inc. | 2.24% |
| 13 | KYMR | Kymera Therapeutics, Inc. | 2.20% |
| 14 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.20% |
| 15 | INSM | Insmed Incorporated | 2.13% |
| 16 | UNH | UnitedHealth Group Incorporated | 2.01% |
| 17 | ASND | Ascendis Pharma A/S | 2.01% |
| 18 | MRNA | Moderna, Inc. | 1.89% |
| 19 | HTFL | HeartFlow, Inc. | 1.88% |
| 20 | EW | Edwards Lifesciences Corporation | 1.87% |
| 21 | KNSA | Kiniksa Pharmaceuticals International, plc | 1.86% |
| 22 | PCVX | Vaxcyte, Inc. | 1.84% |
| 23 | EBR: UCB | UCB SA | 1.74% |
| 24 | GH | Guardant Health, Inc. | 1.69% |
| 25 | LEGN | Legend Biotech Corporation | 1.51% |
As of Aug 10, 2026